Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment

di: Taylor C. Duke, MD, Ranjit Nair, MD, Carlos Torres-Cabala, MD, Rodabe N. Amaria, MD, Elizabeth Keiser, MD, Roberto Miranda, MD, Swaminathan P. Iyer, MD, Meghan Heberton, MD

Natura: Article
Pubblicazione: Elsevier 2020-12-01

Descrizione

Soggetti

angioimmunoblastic T-cell lymphoma; immune checkpoint therapy; metastatic melanoma; pembrolizumab; programmed death-1